Prucalopride Tablet, Film Coated
Product Images NDC 60505-4807

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Prucalopride (NDC 60505-4807). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Apotex Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Btl-lbl-1mg-30s.jpg (Btl Lbl 1mg 30s)

This description provides essential information about prucalopride tablets, each film-coated tablet containing 1 mg of prucalopride (equivalent to 1.32 mg of prucalopride succinate). The recommended storage temperature is between 20°C to 25°C (68°F to 77°F) with excursions allowed between 15°C to 30°C (59°F to 86°F). It is advised to store the tablets in the original container to protect them from moisture and keep them out of reach of children. The usual dose is one tablet once daily. The manufacturer is Apotex Corp. from Toronto, Ontario, Canada.*

FDA Label Image

Btl-lbl-2mg-30s.jpg (Btl Lbl 2mg 30s)

This text provides information on prucalopride tablet composition, storage instructions, manufacturer details, and dosage guidance. Each film-coated tablet contains 2 mg of prucalopride (equivalent to 2.64 mg of prucalopride succinate). The tablets should be stored at 20°C to 25°C but can tolerate excursions from 15°C to 30°C. They need to be stored in the original container to protect them from moisture and kept out of reach of children. The usual dose is one tablet once daily. The tablets are manufactured by Apotex Corp in Toronto, Ontario, Canada.*

FDA Label Image

Structure.jpg (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.